Mario Lazzarino
- Hematology top 0.05%
- Acute Myeloid Leukemia Research 80
- Chronic Myeloid Leukemia Treatments 36
- Multiple Myeloma Research and Treatments 33
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research 60
- Myeloproliferative Neoplasms: Diagnosis and Treatment 44
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 79
- Rheumatology top 0.5%
- Oncology top 1%
- Viral-associated cancers and disorders 29
-
- Acute Lymphoblastic Leukemia research 25
- Co-authors
- Cristiana PascuttoFrancesco PassamontiMario CazzolaLuca ArcainiPaolo BernasconiEnrica MorraMatteo Giovanni Della PortaAlessandro Corso
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Mario Lazzarino
232 papers receiving 9.5k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Hematology 5.6k
- Genetics 5.0k
- Pathology and Forensic Medicine 2.6k
- Rheumatology 1.3k
- Oncology 2.4k
Countries citing papers authored by Mario Lazzarino
This map shows the geographic impact of Mario Lazzarino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Lazzarino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Lazzarino more than expected).
Fields of papers citing papers by Mario Lazzarino
This network shows the impact of papers produced by Mario Lazzarino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Lazzarino. The network helps show where Mario Lazzarino may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mario Lazzarino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 31 | |
| 2 | 2010 | 16 | |
| 3 | 2010 | 14 | |
| 4 | 2009 | 12 | |
| 5 | 2008 | 25 | |
| 6 | 2008 | 40 | |
| 7 | 2007 | 85 | |
| 8 | 2007 | 6 | |
| 9 | 2005 | 7 | |
| 10 | 2003 | 6 | |
| 11 | 2003 | 17 | |
| 12 | 2001 | 8 | |
| 13 | 1997 | 114 | |
| 14 | Clinical and cytologic characteristics of blastic phase in Ph-positive chronic myeloid leukemia treated with alpha-interferon. | 1996 | 5 |
| 15 | 1995 | 9 | |
| 16 | 1994 | 31 | |
| 17 | IL TRATTAMENTO DELLA LEUCEMIA MIELOIDE CRONICA (LMC) CON INTERFERONE ∅-2B (IFN ∅2B) | 1991 | 1 |
| 18 | 1991 | 7 | |
| 19 | 1990 | 21 | |
| 20 | 1989 | 25 |
About Mario Lazzarino
Mario Lazzarino is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 236 papers that have together received 9.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (80 papers), Lymphoma Diagnosis and Treatment (79 papers), Chronic Lymphocytic Leukemia Research (60 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (44 papers), Chronic Myeloid Leukemia Treatments (36 papers), Multiple Myeloma Research and Treatments (33 papers), Viral-associated cancers and disorders (29 papers) and Acute Lymphoblastic Leukemia research (25 papers). The work is most often cited by research in Hematology (5.6k citations), Genetics (5.0k citations) and Pathology and Forensic Medicine (2.6k citations). Mario Lazzarino has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Cristiana Pascutto, Francesco Passamonti, Mario Cazzola, Luca Arcaini, Paolo Bernasconi, Enrica Morra, Matteo Giovanni Della Porta, Alessandro Corso, Luca Malcovati and Elisa Rumi. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.